Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis
| dc.contributor.author | Boz, C. | |
| dc.contributor.author | Ozakbas, S. | |
| dc.contributor.author | Terzi, M. | |
| dc.contributor.author | Turkoglu, R. | |
| dc.contributor.author | Akman, G. | |
| dc.contributor.author | Efendi, H. | |
| dc.contributor.author | Akcali, A. | |
| dc.contributor.author | Tuncer, A. | |
| dc.contributor.author | Yuceyar, N. | |
| dc.contributor.author | Turan, O. F. | |
| dc.contributor.author | Soysal, A. | |
| dc.contributor.author | Koseoglu, M. | |
| dc.contributor.author | Balci, B. P. | |
| dc.contributor.author | Sevim, S. | |
| dc.contributor.author | Altintas, A. | |
| dc.contributor.author | Cilingir, V. | |
| dc.contributor.author | Demirkiran, M. | |
| dc.contributor.author | Kizilay, F. | |
| dc.contributor.author | Altunrende, B. | |
| dc.date.accessioned | 2019-10-27T11:05:04Z | |
| dc.date.available | 2019-10-27T11:05:04Z | |
| dc.date.issued | 2017 | |
| dc.department | Ege Üniversitesi | en_US |
| dc.description | 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) -- OCT 25-28, 2017 -- Paris, FRANCE | en_US |
| dc.description.sponsorship | European Comm Treatment & Res Multiple Sclerosis, Americas Comm Treatment & Res Multiple Sclerosis | en_US |
| dc.description.sponsorship | MerckMerck & Company; NovartisNovartis; Bayer-ScheringBayer AG; Teva | en_US |
| dc.description.sponsorship | Murat Terzi received travel grants from Merck, Novartis, Bayer-Schering, Merck and Teva; has participated in clinical trials by Sanofi Aventis, Roche and Novartis. | en_US |
| dc.identifier.endpage | 328 | en_US |
| dc.identifier.issn | 1352-4585 | |
| dc.identifier.issn | 1477-0970 | |
| dc.identifier.startpage | 327 | en_US |
| dc.identifier.uri | https://hdl.handle.net/11454/31593 | |
| dc.identifier.volume | 23 | en_US |
| dc.identifier.wos | WOS:000413730202068 | en_US |
| dc.identifier.wosquality | Q1 | en_US |
| dc.indekslendigikaynak | Web of Science | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Sage Publications Ltd | en_US |
| dc.relation.ispartof | Multiple Sclerosis Journal | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Real world efficacy and safety of teriflunomide in patients with relapsing-remitting multiple sclerosis | en_US |
| dc.type | Conference Object | en_US |
